Bioactive Compounds
-
BA4045 5-DMT-3-TBDMS-ibu-rGSummary: 5'-DMT-3'-TBDMS-ibu-rG is a modified nucleoside. -
C3785 L-DOPA methyl ester (hydrochloride)Summary: dopamine D1 receptor agonist -
B6226 Kainic acidSummary: Selective kainate receptor agonist; for epilepsy and neurodegenerative disease models -
B2135 UrsodiolSummary: Bile acids for PBC treatment -
B2106 Loteprednol etabonateSummary: potent glucocorticoid receptor agonist -
B1783 Loxapine SuccinateSummary: Dopamine receptor antagonist -
C6859 L-Ornithine L-aspartateSummary: A compound that lowers blood ammonia concentration and relieves hepatic encephalopathy -
C6980 4-Quinolinecarboxylic acidSummary: An endogenous metabolite involved in metabolic pathways and receptor regulation -
A8135 Cy7 carboxylic acid (non-sulfonated)Summary: Cy7 carboxylic acid (non-sulfonated), labels primary amines after EDC/NHS activation or used directly for controls and calibration. -
N2087 DemethyleneberberineSummary: A natural isoquinoline alkaloid from Phellodendron and other traditional Chinese medicines that inhibits NF-κB, MAPK, and c-Myc/HIF-1α signaling and activates AMPK signaling.

